Anti-IL-12 antibody conjugated liposomes hold great potential in ulcerative colitis research by specifically targeting and delivering therapeutic agents to inflammatory sites, thereby enhancing the treatment's efficacy while minimizing systemic side effects. Additionally, their ability to modulate the immune response could lead to novel strategies for controlling inflammation and maintaining remission in patients with this chronic condition.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-393CL | Human Anti-IL-12 Recombinant Antibody (TAB-393CL) | ELISA | Human IgG |
TAB-042ZJ | Anti-Human IL-12 Recombinant Antibody (HAIL-12) | ELISA | Humanized antibody |
TAB-042ZJ-S(P) | Anti-Human IL-12 Recombinant Antibody scFv Fragment (HAIL-12) | ELISA | Humanized antibody |
TAB-042ZJ-F(E) | Anti-Human IL-12 Recombinant Antibody Fab Fragment (HAIL-12) | ELISA | Humanized antibody |
There are currently no Customer reviews or questions for VS-1024-FY286. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.